$NVLX Changes Name to PharmaCyte Biotech

Nuvilex Announces Name Change to PharmaCyte Biotech Company’s Shares Will Trade Under…

$NVLX Execs to Attend 2015 Gastrointestinal Cancers Symposium

Nuvilex to Attend 2015 Gastrointestinal Cancers Symposium in San Francisco, January 15-17,…

$NVLX Gets FDA Orphan Drug Designation

FDA Grants Orphan Drug Designation to Nuvilex for Pancreatic Cancer Treatment SILVER…

$NVLX Gives Update on Partner Austrianova

Nuvilex’s Partner Austrianova Successfully Completes First Live Cell Encapsulation in New Facility…

$NVLX Updates Shareholders

Nuvilex Provides Shareholder Update on Cancer and Diabetes Programs SILVER SPRING, Md.,…

$NVLX Gives Update on Live-Cell Encapsulation Facility

Nuvilex Provides Update on Significance of Austrianova’s cGMP Live-Cell Encapsulation Facility SILVER…

$NVLX Subsidiary Now Viridis Biotech

Nuvilex Announces Name Change of Subsidiary to Viridis Biotech SILVER SPRING, Md.,…

$NVLX To Open Live Cell Encapsulation Facility in Thailand

Nuvilex Announces the Opening of Austrianova’s cGMP Live Cell Encapsulation Facility in…